Introduction to Monoclonal Antibodies for Cancer Therapy Available through Bharatbook

Bharatbook added a new report on "Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025" explains how this market will develop, and where the opportunities will lie.
 
 
Spread the Word
Listed Under

Tags:
Cancer
Antibodies
Therapy
Drugs
Healthcare
Market Research Reports
Aggregator
Company Profile
Company Insight
Finance

Industrys:
Health
Medical

Location:
Navi Mumbai - Maharashtra - India

Aug. 4, 2010 - PRLog -- Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025

In 2009, monoclonal antibodies for cancer therapy generated total revenues of over $18bn worldwide. From 2010, that sector will benefit from new drugs and expanding indications for existing products. ( http://www.bharatbook.com/detail.asp?id=101007&rt=Monoclonal-Antibodies-in-Cancer-Therapy-World-Market-Prospects-2010-2025.html )

Cancer incidence and prevalence are rising worldwide; studies reveal that incidence will rise by up to 40% by 2025. Worldwide, the treatment of cancer is a priority for healthcare providers, with high demand for efficacious and well-tolerated therapies. Where is the monoclonal antibody therapy market for cancer heading - technologically and commercially - from 2010 onwards? Our new report covers such questions, providing the information that you need.

Our new report - Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025 - explains how this market will develop, and where the opportunities will lie. We show how you can benefit from its developments and potential. There remain many unmet therapeutic needs in the treatment of cancer. There is also increasing demand for cancer monoclonal antibodies in developing countries. Novel monoclonal antibodies that demonstrate improved safety profiles – combined with high efficacies – can gain significant market shares from 2010 onwards. There remain high revenues to be made in this sector from 2010 to 2025, our new report explains.

Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025 covers the following monoclonal antibodies in detail:

* Avastin
* Mabthera/Rituxan
* Herceptin
* Erbitux
* Vectibix
* Campath.

What sort of monoclonal antibodies are likely to enter the market from 2010 onwards? Where will the main opportunities lie, and what are the drivers and restraints in this market area? This report will provide you with the information that you need to understand current trends and future directions in the industry and market.

For more information kindly visit : http://www.bharatbook.com/detail.asp?id=101007&rt=Monoclo...            

Related Reports

Monoclonal antibodies: 2009 update
http://www.bharatbook.com/detail.asp?id=124900&rt=Monoclo...

The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
http://www.bharatbook.com/detail.asp?id=126919&rt=The-Fut...

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668  
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Please visit our blog at http://bharatbookseo.blogsome.com 

# # #

Bharat Book Bureau is the leading business information aggregator providing market research reports and online databases. Bharatbook is also into the business of marketing conferences worldwide and undertakes custom research.
End
Source:
Email:***@bharatbook.com Email Verified
Phone:+91 22 27578668
Zip:400614
Tags:Cancer, Antibodies, Therapy, Drugs, Healthcare, Market Research Reports, Aggregator, Company Profile, Company Insight, Finance
Industry:Health, Medical
Location:Navi Mumbai - Maharashtra - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Bharat Book PRs
Trending News
Top Daily News
Top Weekly News



Like PRLog?
9K2K1K
Click to Share